MSD Partners as of Dec. 31, 2017
Portfolio Holdings for MSD Partners
MSD Partners holds 24 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 69.2 | $1.3B | 5.0M | 266.86 | |
| Altaba | 12.4 | $238M | 3.4M | 69.85 | |
| Coty Inc Cl A (COTY) | 7.4 | $142M | 7.1M | 19.89 | |
| Halozyme Therapeutics (HALO) | 2.4 | $46M | 2.2M | 20.26 | |
| National Gen Hldgs | 1.2 | $23M | 1.2M | 19.64 | |
| Hrg | 0.9 | $17M | 1.0M | 16.95 | |
| Novagold Resources Inc Cad (NG) | 0.9 | $17M | 4.2M | 3.93 | |
| Stealthgas (GASS) | 0.8 | $16M | 3.7M | 4.36 | |
| Tribune Co New Cl A | 0.8 | $16M | 365k | 42.47 | |
| Blueknight Energy Partners | 0.7 | $14M | 2.8M | 5.10 | |
| ZIOPHARM Oncology | 0.7 | $14M | 3.4M | 4.14 | |
| Bmc Stk Hldgs | 0.6 | $12M | 482k | 25.30 | |
| Ishares Msci Japan (EWJ) | 0.6 | $12M | 204k | 59.93 | |
| Marten Transport (MRTN) | 0.5 | $10M | 500k | 20.30 | |
| JPMorgan Chase & Co. (JPM) | 0.4 | $8.0M | 75k | 106.93 | |
| Cooper Standard Holdings (CPS) | 0.1 | $2.4M | 20k | 122.49 | |
| Synthetic Biologics | 0.1 | $2.1M | 4.1M | 0.51 | |
| Egalet | 0.1 | $1.0M | 1.0M | 1.00 | |
| Intellia Therapeutics (NTLA) | 0.0 | $577k | 30k | 19.23 | |
| Oragenics Inc New C ommon | 0.0 | $397k | 1.7M | 0.23 | |
| Fibrocell Science | 0.0 | $444k | 693k | 0.64 | |
| Nabriva Therapeutics | 0.0 | $299k | 50k | 5.98 | |
| Alerian Mlp Etf | 0.0 | $132k | 12k | 10.82 | |
| Ampliphi Biosciences | 0.0 | $15k | 15k | 1.00 |
